Want to join the conversation?
Analyst Robert Willoughby asks how $LH will reverse the operating loss at its latest acquisition Sequenom. CEO David King says there are several opportunities. "No. 1 is just improving the laboratory operation â¦ No. 2 is expanding the reach of their sales force and extending that into the primary care and Obstetrics/Gynecology market,â King says.
$BABA seems to be on a roll! But increasing its yearly sales outlook from 48% to 54% seems over-expectation from the company's part, doesn't it?
$JNJ down 2% in pre-market trading. Earnings beat expectations, but sales disappointed. Johnson is cautious on its outlook. How it will perform in the future?
$YHOO is reporting today after market close. Nobody cares about this stock.